| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $181.0M | +31.2% |
| Cost of Revenue | $79.9M | +10.5% |
| Gross Profit | $101.0M | +54.0% |
| R&D Expense | $126.4M | +39.0% |
| SG&A Expense | $90.8M | +41.9% |
| Operating Income | -$146.8M | -31.7% |
| Pre-tax Income | -$149.1M | -47.9% |
| Income Tax | $63K | -84.7% |
| Net Income | -$149.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.5M | -24.8% |
| Short-term Investments | $360.6M | -21.0% |
| Accounts Receivable | $56.0M | +76.3% |
| Current Assets | $534.0M | -14.6% |
| Total Assets | $688.6M | -9.0% |
| Current Liabilities | $108.8M | +19.3% |
| Total Liabilities | $240.7M | +20.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.7M | -69.4% |
| Capital Expenditures | $8.0M | +11.8% |
| Investing Cash Flow | $90.0M | +635.5% |
| Financing Cash Flow | $2.1M | -73.5% |
| Free Cash Flow | -$127.7M | -64.1% |
| -48.6% |
| EPS (Basic) | -$2.10 | -47.9% |
| EPS (Diluted) | -$2.10 | -47.9% |
| Stockholders' Equity |
| $447.9M |
| -19.6% |